12-102958371-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_004316.4(ASCL1):c.127G>A(p.Ala43Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000208 in 1,444,264 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004316.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ASCL1 | NM_004316.4 | c.127G>A | p.Ala43Thr | missense_variant | 1/2 | ENST00000266744.4 | |
PAH | NM_001354304.2 | c.-272C>T | 5_prime_UTR_variant | 1/14 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ASCL1 | ENST00000266744.4 | c.127G>A | p.Ala43Thr | missense_variant | 1/2 | 1 | NM_004316.4 | P1 | |
PAH | ENST00000547319.1 | n.40C>T | non_coding_transcript_exon_variant | 1/3 | 4 | ||||
PAH | ENST00000551337.5 | upstream_gene_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000198 AC: 3AN: 151212Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000163 AC: 1AN: 61526Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 36354
GnomAD4 exome AF: 0.0000209 AC: 27AN: 1293052Hom.: 0 Cov.: 29 AF XY: 0.0000188 AC XY: 12AN XY: 636866
GnomAD4 genome AF: 0.0000198 AC: 3AN: 151212Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 73864
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 17, 2022 | The c.127G>A (p.A43T) alteration is located in exon 1 (coding exon 1) of the ASCL1 gene. This alteration results from a G to A substitution at nucleotide position 127, causing the alanine (A) at amino acid position 43 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at